Antibody Drugs
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
450
NCT01043016
Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2009
Completion: Apr 30, 2010
Loading map...